Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04132804 · ClinicalTrials.gov registry record · NA
Effect of Tai Chi as Treatment for IBS-C
A NA study of Irritable Bowel Syndrome With Constipation, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT04132804: Completed NA study of Irritable Bowel Syndrome With Constipation, sponsored by Massachusetts General Hospital.
NCT04132804 is a NA study of Irritable Bowel Syndrome With Constipation that has completed, run by Massachusetts General Hospital. The registered enrollment target is 31 participants, below the 202-participant average among 3 other Irritable Bowel Syndrome With Constipation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04132804, a NA study of Irritable Bowel Syndrome With Constipation, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate the efficacy of Tai Chi practice in reducing symptoms of Irritable Bowel Syndrome with Constipation (IBS-C).
Primary Outcome
Questionnaire involves yes/no questions, entering numbers, rating scales from 0 to 100, and marking locations of pain. No subscales. Total score is derived by multiplying the number of days of pain (0 to 10) by 10 and summing it with the value from each of 4 scales (0 to 100). Higher total score represents greater symptom severity (min score= 0, max score= 500).
Conditions Studied
Interventions
- BEHAVIORAL Tai Chi
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-07-21 |
| Est. Completion | 2022-07-14 |
| Phase | NA |
What the finished NCT04132804 record still lists
NCT04132804 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 202-participant average among 3 other Irritable Bowel Syndrome With Constipation trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Irritable Bowel Syndrome With Constipation appearing as the primary indexed condition, and to 1 intervention - of which Tai Chi is the first listed.
NCT04132804 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04132804 about?
NCT04132804 is a clinical study titled "Effect of Tai Chi as Treatment for IBS-C". The purpose of the study is to evaluate the efficacy of Tai Chi practice in reducing symptoms of Irritable Bowel Syndrome with Constipation (IBS-C).
What is the current status of trial NCT04132804?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2020-07-21. Estimated completion is 2022-07-14.
What conditions does trial NCT04132804 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome With Constipation.
What interventions are being tested in trial NCT04132804?
The interventions under investigation include: Tai Chi (BEHAVIORAL).
Who is sponsoring clinical trial NCT04132804?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04132804 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome With Constipation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI